Belite Bio to participate in four upcoming investor conferences
Belite Bio, a clinical-stage drug development company focused on degenerative retinal diseases, announced participation in four upcoming investor conferences.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BLTE - Belite Bio to Participate in Four Upcoming Investor Conferences
BLTE - Belite Bio to Participate in Four Upcoming Investor Conferences